Professor Kim Chan
People_

Professor Kim Chan

BPharm (Medal) NDMC Taipei PhD DSc Syd
Professor
Phone
+61 2 9351 3054
Fax
+61 2 9351 4391
Professor Kim Chan

Hak-Kim Chan, Professor in Pharmaceutics is leading the Advanced Drug Delivery Group at the Sydney Pharmacy School. He graduated from the National Defense Medical Center (BPharm, University Medal 1983), University of Sydney (PhD 1988 and DSc 2009), was a postdoc at the University of Minnesota in 1988-89 and a scientist at Genentech Inc in 1992–95.

Professor Chan is a world leader in respiratory drug delivery. He is globally ranked number 1 in the field of Pulmonary Drug Delivery and Inhalation Aerosols (by total number of publications and citations in the last 5 years, data from SciVal), with significant impacts in powder formulations. Over two decades since joining the University of Sydney, he has developed a leading research program on aerosol drug delivery, ranging fromin vitro production methods and characterisation of inhalation aerosols, computational modelling for powder aerosols and inhaler design to in vivo imaging study of aerosol deposition in the lungs and clinical applications. He played a pivotal role in the development of Aridol™ (inhaled mannitol for diagnosis of asthma), which was approved by the FDA in the United States, 14 European Union countries, Singapore, Malaysia, South Korea, Australia and New Zealand. The inhaled mannitol aerosol provides an important disease management tool to millions of asthma sufferers, and is particularly valuable as an objective assessment test for the early detection of asthma in young children. The second product (Bronchitol™) for mucus clearance in cystic fibrosis was also approved and marketed in Europe, Russia, Australia and the United States. This work is listed on the NHMRC website as one of the successful case studies showing its impact on raising individual and public health standard in Australia (https://www.nhmrc.gov.au/about-us/resources/impact-case-studies/aridolr-and-bronchitolr).

He has over 480 publications, including 330 original scientific papers, 92 invited review articles and book chapters, 61 referred extended conference abstracts, and one book: Advances in Pulmonary Drug Delivery, edited by Philip Kwok andHak-Kim Chan, CRC Press, Boca Raton, 2017. He has >17,580 citations and an h-index of 73 (via Google Scholar); and >13,210 citations and an h-index of 63 (via Scopus). Since 2014, he has expanded his expertise to formulation and delivery of inhaled bacteriophages as liquid and powder aerosols. He is listed as the most active author in this area with 15 scholarly outputs and 217 citations (via SciVal). Inhaled formulations offer a safe and efficient strategy to 1) combat multiple drug-resistant superbugs in respiratory infection; 2) reduce systematic toxicity due to local delivery to the lungs. He has 10 patents granted (as the first inventor in 7 patents).

Professor Chan is an Executive Editor ofAdvanced Drug Delivery Reviews (impact factor 13.3; 5 year impact factor is 15.6)and on the editorial advisory boards of various pharmaceutical journals, includingInternational Journal of Pharmaceutics andCurrent Clinical Pharmacology. He is a Fellow of the American Association of Pharmaceutical Scientists (AAPS), and Fellow of Royal Australian Chemical Institute (RACI). He was appointed to the Subcommittee on Pharmaceutical Aerosol Standards for the Australian Therapeutic Goods Administration in 1996–97, and served as a member (2007–08) on thein vitro – in vivocorrelation subgroup of the International Pharmaceutical Aerosol Consortium on Regulation and Science in Washington DC. He also served as Chair of the NSW Pharmaceutical Science Group of the RACI, and Vice President of the Asian Federation for Pharmaceutical Sciences.

Project titleResearch student
Targeting pulmonary bacterial and fungal infections with inhalable repurposed drugsPancy KWONG
Pulmonary delivery of probiotic formulations in respiratory infectionsGrace YAU

Publications

Books

  • Kwok, P., Chan, H. (2016). Advances in Pulmonary Drug Delivery. Boca Raton: CRC Press. [More Information]

Book Chapters

  • Kwok, P., Chan, H. (2019). Solid State Testing of Inhaled Formulations. In Anthony J. Hickey, Sandro R.P. da Rocha (Eds.), Pharmaceutical Inhalation Aerosol Technology, (pp. 523-540). Boca Raton: CRC Press. [More Information]
  • Tong, Z., Yang, R., Chan, H., Yu, A. (2017). Multiphase Flows in Pharmaceutical Applications. In Guan Heng Yeoh, J. B. Joshi (Eds.), Handbook of Multiphase Flow Science and Technology, (pp. 1-24). Singapore: Springer. [More Information]
  • Zhou, Q., Qu, L., Chan, H. (2016). Pulmonary Delivery of Antibiotics for Respiratory Infections. In Philip Chi Lip Kwok, Hak-Kim Chan (Eds.), Advances in Pulmonary Drug Delivery, (pp. 131-150). Boca Raton: CRC Press. [More Information]

Journals

  • Milton-McGurk, L., Kourmatzis, A., Chan, H., Cheng, S., Masri, A., Farina, D. (2024). A new LED-based extinction tomography method for measurement of aerosol surface area. Journal of Aerosol Science, 181, 106432. [More Information]
  • Ma, Z., Milton-McGurk, L., Tang, P., Chan, H., Farina, D., Cheng, S., Kourmatzis, A. (2024). An experimental study of the effect of individual upper airway anatomical features on the deposition of dry powder inhaler formulations. Journal of Aerosol Science, 177, 106320. [More Information]
  • Zhu, Q., Gou, D., Chan, H., Yang, R. (2024). CFD-DEM investigation of the dispersion of elongated particles in the Turbuhaler® aerosol device. Powder Technology, 437, 119565. [More Information]

Conferences

  • Kwok, P., Seungyeon, B., Ong, Y., Bhome, A., Tang, P., Chan, H. (2020). In vitro aerosol performance of originator and generic fixed dose combination metered dose inhalers. Respiratory Drug Delivery 2020, Digital: Respiratory Drug Delivery 2020.
  • Tai, W., Bhome, A., Tang, P., Chan, H., Kwok, P. (2020). In Vitro Aerosol Performance Of Originator And Indian Generic Fixed-dose Combination Dry Powder Inhalers. Respiratory Drug Delivery 2020, Digital: Respiratory Drug Delivery 2020.
  • Leung, S., Parumasivam, T., Gao, G., Carrigy, N., Vehring, R., Finlay, W., Morales, S., Britton, W., Kutter, E., Chan, H. (2017). Production of inhalable bacteriophage dry powders. RDD Europe 2017 Respiratory Drug Delivery, Antibes, France: RDD Europe 2017 Respiratory Drug Delivery.

Patents

  • Chan, H., Gonda, I., Shire, S., Weck, S. (2008). Improved DNase liquid solution. Patent No. CA-2184581-A1, JP-3009224-B2. , Canada.
  • Chan, H., Gonda, I., Shire, S., Weck, S. (2008). Improved DNase liquid solutions. Patent No. EP 0 748 377 B1.
  • Goodall, S., Waters, M., Mahler, S., Chan, H., Chew, N. (2006). Compositions for protein delivery via the pulmonary route. Patent No. EP 1 389 137 B1.

Reference Works

  • Chan, H. (2001). Radiolabelling of Pharmaceutical Aerosols and Gamma Scintigraphic Imaging for Lung Deposition. (Vol. 20, pp. 255-268).

2024

  • Milton-McGurk, L., Kourmatzis, A., Chan, H., Cheng, S., Masri, A., Farina, D. (2024). A new LED-based extinction tomography method for measurement of aerosol surface area. Journal of Aerosol Science, 181, 106432. [More Information]
  • Ma, Z., Milton-McGurk, L., Tang, P., Chan, H., Farina, D., Cheng, S., Kourmatzis, A. (2024). An experimental study of the effect of individual upper airway anatomical features on the deposition of dry powder inhaler formulations. Journal of Aerosol Science, 177, 106320. [More Information]
  • Zhu, Q., Gou, D., Chan, H., Yang, R. (2024). CFD-DEM investigation of the dispersion of elongated particles in the Turbuhaler® aerosol device. Powder Technology, 437, 119565. [More Information]

2023

  • Wang, Y., Khanal, D., Alreja, A., Yang, H., Chang, R., Tai, W., Li, M., Nelson, D., Britton, W., Chan, H. (2023). Bacteriophage endolysin powders for inhaled delivery against pulmonary infections. International Journal of Pharmaceutics, 635. [More Information]
  • Yau, G., Tai, W., Arnold, J., Chan, H., Kwok, P. (2023). Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration. Pharmaceutical Research. [More Information]
  • Zhu, Q., Kakhi, M., Jayasundara, C., Walenga, R., Behara, S., Chan, H., Yang, R. (2023). CFD-DEM investigation of the effects of aperture size for a capsule-based dry powder inhaler. International Journal of Pharmaceutics, 647, 123556. [More Information]

2022

  • Chang, R., Li, M., Chow, M., Ke, W., Tai, W., Chan, H. (2022). A dual action of D-amino acids on anti-biofilm activity and moisture-protection of inhalable ciprofloxacin powders. European Journal of Pharmaceutics and Biopharmaceutics, 173, 132-140. [More Information]
  • Chang, R., Chan, H. (2022). Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics. Pharmaceutical Research, 39(12), 3047-3061. [More Information]
  • Wang, Y., Chang, R., Britton, W., Chan, H. (2022). Advances in the development of antimicrobial peptides and proteins for inhaled therapy. Advanced Drug Delivery Reviews, 180, 114066. [More Information]

2021

  • Yaqoubi, S., Chan, H., Nokhodchi, A., Dastmalchi, S., Alizadeh, A., Barzegar-Jalali, M., Adibkia, K., Hamishehkar, H. (2021). A quantitative approach to predicting lung deposition profiles of pharmaceutical powder aerosols. International Journal of Pharmaceutics, 602, 120568. [More Information]
  • Ke, W., Chang, R., Kwok, P., Tang, P., Chen, L., Chen, D., Chan, H. (2021). Administration of dry powders during respiratory supports. Annals of Translational Medicine, 9(7), 596. [More Information]
  • Kim, H., Chang, R., Morales, S., Chan, H. (2021). Bacteriophage-delivering hydrogels: Current progress in combating antibiotic resistant bacterial infection. Antibiotics, 10(2), 130-1-130-17. [More Information]

2020

  • Khanal, D., Zhang, J., Ke, W., Banaszak Holl, M., Chan, H. (2020). Bulk to Nanometer-Scale Infrared Spectroscopy of Pharmaceutical Dry Powder Aerosols. Analytical Chemistry, 92(12), 8323-8332. [More Information]
  • Wang, Y., Khanal, D., Chang, R., Shang, X., Yang, H., Britton, W., Nelson, D., Chan, H. (2020). Can bacteriophage endolysins be nebulised for inhalation delivery against Streptococcus pneumoniae? International Journal of Pharmaceutics, 591, 1-8. [More Information]
  • Chang, R., Kwok, P., Ghassabian, S., Brannan, J., Koskela, H., Chan, H. (2020). Cough as an adverse effect on inhalation pharmaceutical products. British Journal of Pharmacology, 177(18), 4096-4112. [More Information]

2019

  • Khoubnasabjafari, M., Rahimpour, E., Samini, M., Jouyban-Gharamaleki, V., Chen, L., Chen, D., Chan, H., Jouyban, A. (2019). A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products. DARU Journal of Pharmaceutical Sciences, 27(1), 517-524. [More Information]
  • Wallin, M., Tang, P., Chang, R., Yang, M., Finlay, W., Chan, H. (2019). Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study. BMC Pulmonary Medicine, 19(1), 1-11. [More Information]
  • Abdelghany, S., Parumasivam, T., Pang, A., Roediger, B., Tang, P., Jahn, K., Britton, W., Chan, H. (2019). Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis. Journal of Drug Delivery Science and Technology, 52, 642-651. [More Information]

2018

  • Dhanani, J., Cohen, J., Parker, S., Chan, H., Tang, P., Ahern, B., Khan, A., Bhatt, M., Goodman, S., Diab, S., et al (2018). A research pathway for the study of the delivery and disposition of nebulised antibiotics: an incremental approach from in vitro to large animal models. Intensive Care Medicine Experimental, 6(1), 1-19. [More Information]
  • Le, N., Phan, H., Yu, J., Chan, H., Neild, A., Alan, T. (2018). Acoustically enhanced microfluidic mixer to synthesize highly uniform nanodrugs without the addition of stabilizers. International Journal of Nanomedicine, 13, 1353-1359. [More Information]
  • Reczynska, K., Tharkar, P., Kim, S., Wang, Y., Pamula, E., Chan, H., Chrzanowski, W. (2018). Animal Models of Smoke Inhalation Injury and Related Acute and Chronic Lung Diseases. Advanced Drug Delivery Reviews, 123, 107-134. [More Information]

2017

  • Feng, B., Tang, P., Leung, S., Dhanani, J., Chan, H. (2017). A Novel In-Line Delivery System to Administer Dry Powder Mannitol to Mechanically Ventilated Patients. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 30(2), 100-107. [More Information]
  • Lin, Y., Zhou, Q., Onufrak, N., Wirth, V., Chen, K., Wang, J., Forrest, A., Chan, H., Li, J. (2017). Aerosolized polymyxin B for treatment of respiratory tract infections: Determination of pharmacokinetic-pharmacodynamic indices for aerosolized polymyxin B against Pseudomonas aeruginosa in a mouse lung infection model. Antimicrobial Agents and Chemotherapy, 61(8), 1-15. [More Information]
  • Kourmatzis, A., Cheng, S., Chan, H. (2017). Airway geometry, airway flow, and particle measurement methods: implications on pulmonary drug delivery. Expert Opinion on Drug Delivery, 15(3), 271-282. [More Information]

2016

  • Leung, S., Parumasivam, T., Tang, P., Chan, H. (2016). A Proof-of-Principle Setup for Delivery of Relenza (Zanamivir) Inhalation Powder to Intubated Patients. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 29(1), 30-35. [More Information]
  • Le,, N., Yu, J., Phan,, H., Neild,, A., Chan, H., Alan,, T. (2016). Acoustic-enhanced 3D T junction for nanodrug crystallization. 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2016, : Springer Verlag.
  • Kwok, P., Chan, H. (2016). Advances in Pulmonary Drug Delivery. Boca Raton: CRC Press. [More Information]

2015

  • Lee, S., Teo, J., Heng, D., Zhao, Y., Ng, W., Chan, H., Tan, L., Tan, R. (2015). A novel inhaled multi-pronged attack against respiratory bacteria. European Journal of Pharmaceutical Sciences, 70, 37-44. [More Information]
  • D'Sa, D., Chan, H. (2015). A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers. Current Pharmaceutical Design, 21(27), 3955-3965. [More Information]
  • Cipolla, D., Wu, H., Gonda, I., Chan, H. (2015). Aerosol performance and stability of liposomes containing ciprofloxacin nanocrystals. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 28(6), 411-422. [More Information]

2014

  • Chan, J., Duke, C., Ong, H., Chan, J., Tyne, A., Chan, H., Britton, W., Young, P., Traini, D. (2014). A Novel Inhalable Form of Rifapentine. Journal of Pharmaceutical Sciences, 103(5), 1141-1421. [More Information]
  • Chan, J., Tyne, A., Pang, A., Chan, H., Young, P., Britton, W., Duke, C., Traini, D. (2014). A Rifapentine-Containing Inhaled Triple Antibiotic Formulation for Rapid Treatment of Tubercular Infection. Pharmaceutical Research, 31(5), 1239-1253. [More Information]
  • Chan, J., Wong, J., Zhou, Q., Leung, S., Chan, H. (2014). Advances in Device and Formulation Technologies for Pulmonary Drug Delivery. AAPS PharmSciTech, 15(4), 882-897. [More Information]

2013

  • Chan, J., Chan, H., Prestidge, C., Denman, J., Young, P., Traini, D. (2013). A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics. European Journal of Pharmaceutics and Biopharmaceutics, 83(2), 285-292. [More Information]
  • Chan, J., Tyne, A., Chan, H., Young, P., Britton, W., Duke, C., Traini, D. (2013). A novel inhaled antibiotic powder to shorten treatment time for latent tuberculosis. RDD Europe 2013 Respiratory Drug Delivery, Richmond, VA: Virginia Commonwealth University.
  • D'Addio, S., Chan, J., Kwok, P., Benson, B., Prud'homme, R., Chan, H. (2013). Aerosol Delivery of Nanoparticles in Uniform Mannitol Carriers Formulated by Ultrasonic Spray Freeze Drying. Pharmaceutical Research, 30(11), 2891-2901. [More Information]

2012

  • De Boer, A., Chan, H., Price, R. (2012). A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect? Advanced Drug Delivery Reviews, 64(3), 257-274. [More Information]
  • Chan, J., Chan, H., Young, P., Traini, D. (2012). An Inhaled Triple Antibiotic Dry Powder Formulation for the Treatment of Tuberculosis. Respiratory Drug Delivery (RDD 2012 Arizona), Richmond: Virginia Commonwealth University.
  • Heng, D., Lee, S., Kwek, J., Ng, W., Chan, H., Tan, R. (2012). Assessing the combinatorial influence of climate, formulation and device on powder aerosolization using the Taguchi experimental design. Powder Technology, 226, 253-260. [More Information]

2011

  • Adi, S., Adi, H., Chan, H., Finlay, W., Tong, Z., Yang, R., Yu, A. (2011). Agglomerate strength and dispersion of pharmaceutical powders. Journal of Aerosol Science, 42(4), 285-294. [More Information]
  • Yamasaki, K., Kwok, P., Fukushige, K., Prud'homme, R., Chan, H. (2011). Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former. International Journal of Pharmaceutics, 420(1), 34-42. [More Information]
  • Zhang, J., Wu, L., Chan, H., Watanabe, W. (2011). Formation, characterization, and fate of inhaled drug nanoparticles. Advanced Drug Delivery Reviews, 63(6), 441-455. [More Information]

2010

  • Syed Muhammad, S., Langrish, T., Tang, P., Adi, H., Chan, H., Kazarian, S., Dehghani, F. (2010). A novel method for the production of crystalline micronised particles. International Journal of Pharmaceutics, 388(1-2), 114-122. [More Information]
  • Adi, S., Adi, H., Chan, H., Yang, R., Yu, A., Tong, Z. (2010). Agglomerate Strength and Aerosol Performance of API-Only Powders. RDD 2010 Florida Respiratory Drug Delivery, United States: Davis Healthcare International Publishing.
  • Kumon, M., Kwok, P., Adi, H., Heng, D., Chan, H. (2010). Can low-dose combination products for inhalation be formulated in single crystalline particles? European Journal of Pharmaceutical Sciences, 40(1), 16-24. [More Information]

2009

  • Syed Muhammad, S., Langrish, T., Chan, H., Tang, P., Dehghani, F. (2009). A new method for he production of crystalline microparticle. 9th International Symposium on Supercritical Fluids (ISSF) 2009, Arcachon, France.
  • Kwok, P., Glover, W., Chan, H. (2009). Aerosol Performance of Bovine Serum Albumin Nano-matrices for Inhalation. Asian Federation for Pharmaceutical Sciences (AFPS) 2009 Conference, Japan: Kumamoto University.
  • Hoe, S., Young, P., Chan, H., Traini, D. (2009). Application of the Electrical Next Generation Impactor (eNGI) for the Electrostatic Characterization of Commercial Dry Powder Inhaler Formulations. RDD Europe 2009 Respiratory Drug Delivery, Illinois, USA: Davis Healthcare International Publishing.

2008

  • Chiou, H., Chan, H., Heng, D., Prud'homme, R., Raper, J. (2008). A novel production method for inhalable cyclosporine A powders by confined liquid impinging jet precipitation. Journal of Aerosol Science, 39(6), 500-509. [More Information]
  • Yang, R., Yu, A., Choi, S., Coates, M., Chan, H. (2008). Agglomeration of fine particles subjected to centripetal compaction. Powder Technology, 184(1), 122-129. [More Information]
  • Young, P., Roberts, D., Chiou, H., Rae, W., Chan, H., Traini, D. (2008). Composite carriers improve the aerosolisation efficiency of drugs for respiratory delivery. Journal of Aerosol Science, 39, 82-93. [More Information]

2007

  • Adi, H., Young, P., Chan, H., Traini, D., Stewart, P. (2007). Cospray dried antibiotics for dry powder inhalation delivery. RDD Europe 2007 Respiratory Drug Delivery, Illinois, USA: Davis Healthcare International Publishing. [More Information]
  • Adi, H., Young, P., Chan, H., Stewart, P., Agus, H., Traini, D. (2007). Cospray dried antibiotics for dry powder lung delivery. Journal of Pharmaceutical Sciences, online(DOI 10.1002/jps.21239), 1-11. [More Information]
  • Chan, H., Young, P., Traini, D., Coates, M. (2007). Dry powder inhalers: challenges and goals for next generation therapies. Pharmaceutical Technology Europe, 19(4), 19-24.

2006

  • Goodall, S., Waters, M., Mahler, S., Chan, H., Chew, N. (2006). Compositions for protein delivery via the pulmonary route. Patent No. EP 1 389 137 B1.
  • Chan, H., Gonda, I., Shire, S., Weck, S. (2006). DNase liquid solutions. Patent No. 7,018,825 B2.
  • Chan, H. (2006). Dry powder aerosol delivery systems: current and future research directions. Journal of Aerosol Medicine, 19(1), 21-27. [More Information]

2005

  • Jouyban, A., Chew, N., Chan, H., Sabour, M., Acree, W. (2005). A Unified Cosolvency Model for Calculating Solute Solubility in Mixed Solvents. Chemical and Pharmaceutical Bulletin, 53(6), 634-637. [More Information]
  • Koskela, H., Martens, R., Brannan, J., Anderson, S., Leuppi, J., Chan, H. (2005). Dissociation in the effect of nedocromil on mannitol-induced cough or bronchoconstriction in asthmatic subjects. Respirology, 10, 442-448. [More Information]
  • Chew, N., Shekunov, B., Tong, H., Chow, A., Savage, C., Wu, J., Chan, H. (2005). Effect of amino acids on the dispersion of disodium cromoglycate powders. Journal of Pharmaceutical Sciences, 94(10), 2289-2300. [More Information]

2004

  • Jouyban, A., Soltanpour, S., Chan, H. (2004). A Simple Relationship Between Dielectric Constant Of Mixed Solvents With Solvent Composition And Temperature. International Journal of Pharmaceutics, 269(2), 353-360. [More Information]
  • Koskela, H., Hyvarinen, L., Brannan, J., Chan, H., Anderson, S. (2004). Coughing During Mannitol Challenge Is Associated With Asthma. Chest, 125(6), 1985-1992. [More Information]
  • Coates, M., Fletcher, D., Chan, H., Raper, J. (2004). Effect Of Design On The Performance Of A Dry Powder Inhaler Using Computational Fluid Dynamics. Part 1: Grid Structure And Mouthpiece Length. Journal of Pharmaceutical Sciences, 93(11), 2863-2876. [More Information]

2003

  • Jouyban, A., Jabbaribar, F., Chan, H. (2003). An improved empirical model to calculate solute solubility in supercritical carbon dioxide. Die Pharmazie: an international journal of pharmaceutical sciences, 58(6), 396-398.
  • Jouyban, A., Chan, H., Khoubnasabjafari, M., Clark, B. (2003). Calculation of electrophoretic mobility in ternary solvent electrolyte systems. Journal of Pharmaceutical and Biomedical Analysis, 32(2), 203-208. [More Information]
  • Jouyban, A., Chan, H., Clark, B., Kenndler, E. (2003). Comparison of different algorithms to calculate electrophoretic mobility of analytes as a function of binary solvent composition. Electrophoresis, 24(10), 1596-1602. [More Information]

2002

  • Jouyban, A., Romero, S., Chan, H., Clark, B., Bustamante, P. (2002). A cosolvency model to predict solubility of drugs at several temperatures from a limited number of solubility measurements. Chemical and Pharmaceutical Bulletin, 50(5), 594-599. [More Information]
  • Jouyban, A., Chan, H., Barzegar-Jalali, M., Acree, W. (2002). A model to represent solvent effects on the chemical stability of solutes in mixed solvent systems. International Journal of Pharmaceutics, 243(1-2), 167-172. [More Information]
  • Lam, Y., Bustami, R., Phan, T., Chan, H., Seoarivuc, F. (2002). A solid-state NMR study of protein mobility in lyophilized protein-sugar powders. Journal of Pharmaceutical Sciences, 91(4), 943-951. [More Information]

2001

  • Chan, H., Eberl, S., Daviskas, E., Constable, C., Young,, I. (2001). Aerosol deposition and clearance measurement: a novel technique using dynamic SPET. European Journal of Nuclear Medicine and Molecular Imaging, 28, 1365-1372.
  • Chew, N., Chan, H., Bagster, D. (2001). Characterisation of dry powder inhalers: estimation of energy input and effect due to presence of capsule on powder dispersion. Annual Conference, : Ads & Adea.
  • Chew, N., Chan, H. (2001). Determinants for dispersion of powders as aerosols for inhalation. ANZSRS, : World Scientific Publishing.

Selected Grants

2023

  • Rewarding Research 2024, Chan H, Faculty of Medicine and Health/FMH Rewarding Research Success
  • Development of a laser-based testing platform for generic dry powder inhaler (DPI) products and in-silico model validation, Kourmatzis A, Chan H, Milton-McGurk L, The Food and Drug Administration (USA)/Research Support

2022

  • Treating Pulmonary Pseudomonas Infections with Bacteriophage Therapy (TERMINATE- TRIALS), Chan H, Department of Health and Aged Care (Federal)/MRFF - PPHRI - 2021 Chronic Respiratory Conditions Grant
  • Identification of Drug Distribution in Aerosols: A Nanospectroscopy and NanoThermal Analysis, Chan H, Khanal D, The Food and Drug Administration (USA)/Research Support
  • Unravelling the mechanics of particle deposition at the micro-scale, Chan H, Kourmatzis A, Australian Research Council (ARC)/Discovery Projects (DP)
  • Development of inhaled therapeutics using endolysin, Chang R, Chan H, Ministry of Trade, Industry and Energy (KOREA)/Industrial Technology Innovation Program
  • Inhaled phage-antibiotic therapy for combating respiratoryinfections caused by superbugs, Chan H, Cho Y, Chang R, Department of Foreign Affairs and Trade (Federal)/Australia-Korea Foundation

Related research articles

next slide
previous slide